The Global Pharmaceutical Outsourcing Market Was Worth USD57.2 Billion In 2007

Business Wire, March 28, 2008

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c86978) has announced the addition of "Contract Research Manufacturing & Services" to their offering.

Increasing costs of R&D, coupled with low productivity and poor bottom lines, have forced major pharmaceutical companies worldwide to outsource part of their research and manufacturing activities to low-cost countries, thereby saving costs and time in the process. The global pharmaceutical outsourcing market was worth USD57.2 billion in 2007. It is expected to grow at a CAGR of 10% to reach USD76 billion by 2010. Global market for Contract Research and Manufacturing Services (CRAMS) in 2007 is estimated to be USD55.48 billion. Out of the total global CRAMS market, contract research was USD16.58 billion, growing at a CAGR of 13.8% and contract manufacturing was USD38.89 billion accounting for the major share (approximately 68%) of the total global pharmaceutical outsourcing market.

India, with more than 80 US FDA-approved manufacturing facilities, is one of the most preferred locations for outsourcing manufacturing services in India by the multinationals and global pharmaceutical companies. The Indian pharmaceutical outsourcing market was valued at USD1.27m in 2007 and is expected to reach USD3.33 billion by 2010, growing at a CAGR of 37.6%. The Indian CRAMS market stood at USD1.21 billion in 2007, and is estimated to reach USD3.16 billion by 2010. This report gains significance in view of the growing prospects of CRAMS and the increasing interest of Indian pharma companies in exploiting the current opportunities. CRAMS report provides a brief introduction on CRAMS industry, market overview, India-China emerging players. CRAMS report updates on industrial applications in Pharma, Biotechnology and data management industry. It also highlights the growth drivers, issues and challenges in CRAMS industry. It has profiled 20 companies providing introduction, operational details excluding financial details of the companies. CRAMS report presents information about the regulatory issues involved including regulatory systems in India and the government policies. CRAMS report identifies critical success factors involved in the manufacturing/production and research. At the end the report presents future outlook for CRAMS industry.

Companies Mentioned:

- AVRA Laboratories Pvt. Ltd.

- BioArc Research Solutions

- Biocon

- Cadila Healthcare

- Chembiotek Research International

- Dishman Pharmaceuticals and Chemicals Ltd.

- Divis Lab

- Ind-Swift Laboratories Ltd.

- Ipca Laboratories Limited

- JB Chemicals and Pharmaceuticals Ltd.

- Jubilant Organosys Ltd.

- Matrix Laboratories Ltd.

- Nicholas Piramal

- Orchid Pharmaceuticals

- Reliance Research and Development Services

- Sai Life Sciences Ltd.

- Shashun Chemicals & Drugs Ltd.

- Suven Life Sciences Ltd.

- Vimta Labs Limited

- Wockhardt Ltd.

For more information, visit http://www.researchandmarkets.com/reports/c86978